A Study to Compare the Pharmacokinetics and Safety of Current Factor VIII Concentrate and Optivate® in Haemophilia A.
NCT02246881
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
OTHER
Sponsor class
Conditions
Von Willebrand Disease
Interventions
BIOLOGICAL:
Optivate® (Human Coagulation Factor VIII)
Sponsor
Bio Products Laboratory